Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)

Conclusions
This patient-centred collaboration has produced two COM sets for paediatric and adult severe asthma. It is expected that they will inform the methodology of future clinical trials, enhance comparability of efficacy and effectiveness of biological therapies, and help assess their socioeconomic value. COMSA will inform definitions of non-response and response to biological therapy for severe asthma.

Source: European Respiratory Journal - April 3, 2023 Category: Respiratory Medicine Authors: Khaleva, E., Rattu, A., Brightling, C., Bush, A., Bossios, A., Bourdin, A., Chung, K. F., Chaudhuri, R., Coleman, C., Dahlen, S.-E., Djukanovic, R., Deschildre, A., Fleming, L., Fowler, S. J., Gupta, A., Hamelmann, E., Hashimoto, S., Hedlin, G., Koppelman Tags: Asthma and allergy Reviews Source Type: research